Zhu J - Search Results

1

Sex, Race, and Age Disparities in the Improvement of Survival for Gastrointestinal Cancer over Time.

Wan JF, Yang LF, Shen YZ, Jia HX, Zhu J, Li GC, Zhang Z. Wan JF, et al. Among authors: zhu j. Sci Rep. 2016 Jul 13;6:29655. doi: 10.1038/srep29655. Sci Rep. 2016. PMID: 27406065 Free PMC article.

2

Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients.

Zhu J, Xu Y, Gu W, Peng J, Cai G, Cai G, Sun W, Shen W, Cai S, Zhang Z. Zhu J, et al. Radiat Oncol. 2010 Dec 15;5:118. doi: 10.1186/1748-717X-5-118. Radiat Oncol. 2010. PMID: 21156077 Free PMC article.

3

Phase II trial of first-line chemoradiotherapy with intensity-modulated radiation therapy followed by chemotherapy for synchronous unresectable distant metastases rectal adenocarcinoma.

Zhu J, Lian P, Liu F, Xu Y, Xu J, Guan Z, Liang L, Wang M, Cai S, Zhang Z. Zhu J, et al. Radiat Oncol. 2013 Jan 7;8:10. doi: 10.1186/1748-717X-8-10. Radiat Oncol. 2013. PMID: 23295152 Free PMC article. Clinical Trial.

4

Postoperative chemoradiotherapy combined with epirubicin-based triplet chemotherapy for locally advanced adenocarcinoma of the stomach or gastroesophageal junction.

Li G, Zhang Z, Ma X, Zhu J, Cai G. Li G, et al. Among authors: zhu j. PLoS One. 2013;8(1):e54233. doi: 10.1371/journal.pone.0054233. Epub 2013 Jan 25. PLoS One. 2013. PMID: 23372688 Free PMC article.

5

Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older.

Cai X, Wu H, Peng J, Zhu J, Cai S, Cai G, Zhang Z. Cai X, et al. Among authors: zhu j. Radiat Oncol. 2013 Apr 10;8:86. doi: 10.1186/1748-717X-8-86. Radiat Oncol. 2013. PMID: 23574985 Free PMC article.

6

A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma.

Zhu J, Gu W, Lian P, Sheng W, Cai G, Shi D, Cai S, Zhang Z. Zhu J, et al. Radiat Oncol. 2013 May 29;8:130. doi: 10.1186/1748-717X-8-130. Radiat Oncol. 2013. PMID: 23718210 Free PMC article. Clinical Trial.

7

Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.

Cai G, Xu Y, Zhu J, Gu WL, Zhang S, Ma XJ, Cai SJ, Zhang Z. Cai G, et al. Among authors: zhu j. World J Gastroenterol. 2013 Sep 7;19(33):5520-7. doi: 10.3748/wjg.v19.i33.5520. World J Gastroenterol. 2013. PMID: 24023496 Free PMC article. Clinical Trial.

8

The advantage of circulating tumor cells over serum carcinoembryonic antigen for predicting treatment responses in rectal cancer.

Sun W, Huang T, Li G, Shen W, Zhu J, Jin Q, Zhao J, Jia C, Zhang Z. Sun W, et al. Among authors: zhu j. Future Oncol. 2013 Oct;9(10):1489-500. doi: 10.2217/fon.13.91. Future Oncol. 2013. PMID: 24106900

9

MicroRNA-223 enhances radiation sensitivity of U87MG cells in vitro and in vivo by targeting ataxia telangiectasia mutated.

Liang L, Zhu J, Zaorsky NG, Deng Y, Wu X, Liu Y, Liu F, Cai G, Gu W, Shen L, Zhang Z. Liang L, et al. Among authors: zhu j. Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):955-60. doi: 10.1016/j.ijrobp.2013.12.036. Int J Radiat Oncol Biol Phys. 2014. PMID: 24606854

10

Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study.

Zhu J, Liu F, Gu W, Lian P, Sheng W, Xu J, Cai G, Shi D, Cai S, Zhang Z. Zhu J, et al. Radiat Oncol. 2014 Mar 7;9:70. doi: 10.1186/1748-717X-9-70. Radiat Oncol. 2014. PMID: 24606870 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,956 results

Search Page

Filters